Probably Genetic raises $12M to scale rare disease dataset, support drug discovery
The company’s core product is a physician-ordered genetic test for undiagnosed rare disease patients, who typically face a seven-year diagnostic odyssey before getting answers.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.